Type 2 diabetes (T2D) is a progressive metabolic condition associated with obesity, cardiovascular disease and substantial morbidity and mortality.1 Despite the availability of multiple glucose-lowering therapies, a significant proportion of individuals with T2D fail to achieve recommended glycemic targets, particularly those with long disease duration, obesity and insulin resistance.2,3 In parallel, excess adiposity remains a major driver of […]
Advertisement
touchENDOCRINOLOGY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Save your progress for video
Keep track of your CME credits
Add personalised learning notes
Receive updates from course leaders and faculty
Be the first to hear about new and exciting interactive learning opportunities
Register Register
Login
Login
Sign Up FREE
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Register now for FREE Access
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.